GE Healthcare, BGI Partner on Stem Cell Research

Jun 12, 2012

|

NEW YORK (GenomeWeb News) – GE Healthcare and BGI today announced a multi-year research collaboration to explore the underlying genetic variation between ethnically diverse human stem cell lines.

The goal of the deal, whose terms were not disclosed, is to advance the use of stem cell-derived assays in drug discovery and toxicity testing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Under the Watchful Smart Device Eye

Newsweek discusses the privacy issues raised by digital medicine.

The Poor P Value

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

This Week in Nature

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Push for Predictive Genetic Tests

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Featured White Papers

The Ultimate Guide to Mouse Clinical Trials

Mar

27

Featured Webinar

How One NGS Core Lab Reduced Sequencing Costs with a Novel Library Normalization Kit

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.

Apr

30

Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

Menu